title: Quality of life and supportive care in multiple myeloma.
abstract: Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient's quality of life and also can improve survival. The aim of this review is to highlight the relationship among life of quality, supportive care, and improvement in survival.
  
  
  BACKGROUND
  None declared.
authors.affiliation: Ege University School of Medicine, Department of Hematology, İzmir, Turkey.
authors.forename: Melda
authors.initials: M
authors.lastname: Cömert
authors.affiliation: Ege University School of Medicine, Department of Hematology, İzmir, Turkey.
authors.forename: Ajda Ersoy
authors.initials: AE
authors.lastname: Güneş
authors.affiliation: Ege University School of Medicine, Department of Hematology, İzmir, Turkey.
authors.forename: Fahri
authors.initials: F
authors.lastname: Sahin
authors.affiliation: Ege University School of Medicine, Department of Hematology, İzmir, Turkey.
authors.forename: Güray
authors.initials: G
authors.lastname: Saydam
keywords: Multiple myeloma; Quality of life; Supportive care